Merck KGaA (MKKGY) Financials
MKKGY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 60.8 billion | 26.6 billion |
| Dec. 31, 2025 | 61.1 billion | 27.5 billion |
| Sept. 30, 2025 | 59.8 billion | 25.7 billion |
| June 30, 2025 | 55.8 billion | 22.4 billion |
MKKGY Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 311.7 million | ? |
| Dec. 31, 2025 | 996.0 million | ? |
| Sept. 30, 2025 | 1.2 billion | ? |
| June 30, 2025 | 145.0 million | ? |
MKKGY Net Income
| Date | Net Income |
|---|---|
| March 31, 2026 | 766.6 million |
| Dec. 31, 2025 | 371.0 million |
| Sept. 30, 2025 | 1.1 billion |
| June 30, 2025 | 772.0 million |
MKKGY Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 4.3 billion | - | - |
| Dec. 31, 2025 | 3.2 billion | 12.0 billion | 616.1 million |
| Sept. 30, 2025 | 3.4 billion | - | - |
| June 30, 2025 | 1.9 billion | - | - |
MKKGY Shares Outstanding
MKKGY Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 625.7 million | 754.0 million | 1.7 billion | 1.3 billion |
| Dec. 31, 2025 | 481.4 million | 772.2 million | 1.8 billion | - |
| Sept. 30, 2025 | 541.0 million | 774.5 million | 1.7 billion | 1.3 billion |
| June 30, 2025 | 523.3 million | 635.3 million | 1.7 billion | 1.3 billion |
MKKGY Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 5.9 billion | 2.4 billion |
| Dec. 31, 2025 | 6.1 billion | 2.7 billion |
| Sept. 30, 2025 | 6.2 billion | 2.5 billion |
| June 30, 2025 | 6.2 billion | 2.6 billion |
MKKGY
Price: $31.32
Dividend Yield: 1.59%
Forward Dividend Yield: 1.06%
Payout Ratio: 35.30%
Dividend Per Share: 0.34 USD
Earnings Per Share: 1.35 USD
P/E Ratio: 20.67
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 70.5 billion
Average Dividend Frequency: 1
Years Paying Dividends: 19